Company
United StatesPublic company, NYSE: CAHCardinal Health (NYSE: CAH), Glendale Heights, IL – FDA Inspections
Inspection records and compliance data for Cardinal Health in Glendale Heights, Illinois. 3 FDA inspections on record, 1 Form 483, 1 warning letter, last inspected August 15, 2025. Publicly traded as NYSE: CAH.
Company Profile
This profile covers Cardinal Health based in Glendale Heights, Illinois, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 2
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 1
First inspected November 14, 2013. Last inspected August 15, 2025.
Most cited issue areas
- Lab sampling and test procedures1 inspection
- Master Production and Control Records1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 15, 2025 | VAI | Human Drugs · Drug Quality Assurance | 1278538 |
| June 16, 2016 | NAI | Human Drugs · Drug Quality Assurance | 976151 |
| November 14, 2013 | VAI | Human Drugs · Drug Quality Assurance | 855209 |
FDA documents
Form 483s (1)
Warning Letters (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Cardinal Health
Stock ticker
CAH
Exchange
NYSE
Share price
$278.14
Market cap
$64.3B
Price as of
November 13, 2026
FEI Number
3009710633
Address
1950 Bentley Ct Ste 100, Glendale Heights, Illinois 60139, United States
Country
United States
ID: c79cee39-5a53-4323-a195-ca4aa41a84e1